HybridDesign
Hybrid Design for Phase I Dose-Finding Studies
The Hybrid design is a combination of model-assisted design (e.g., the modified Toxicity Probability Interval design) with dose-toxicity model-based design for phase I dose-finding studies. The hybrid design controls the overdosing toxicity well and leads to a recommended dose closer to the true maximum tolerated dose (MTD) due to its ability to calibrate for an intermediate dose. More details can be found in Liao et al. 2022 doi:10.1002/ijc.34203.
- Version1.0
- R versionunknown
- LicenseGPL-3
- Needs compilation?No
- Last release12/15/2022
Team
Heng Zhou
Jason Liao
Show author detailsRolesAuthorFeng Zhou
Show author detailsRolesAuthor
Insights
Last 30 days
Last 365 days
The following line graph shows the downloads per day. You can hover over the graph to see the exact number of downloads per day.
Data provided by CRAN
Binaries
Dependencies
- Imports2 packages